Search Results - "FALOTICO, Robert"

Refine Results
  1. 1

    Polymers for drug eluting stents by Parker, Ted, Davé, Vipul, Falotico, Robert

    Published in Current pharmaceutical design (01-12-2010)
    “…Currently approved drug eluting stents (DES) consist of a metallic scaffold and an elutable drug dispersed in a polymer matrix that conformally surrounds the…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model by SUZUKI, Takeshi, KOPIA, Greg, YEUNG, Alan C, TIO, Fermin, TSAO, Philip S, FALOTICO, Robert, CARTER, Andrew J, HAYASHI, Shin-Ichiro, BAILEY, Lynn R, LLANOS, Gerard, WILENSKY, Robert, KLUGHERZ, Bruce D, PAPANDREOU, George, NARAYAN, Pallassana, LEON, Martin B

    Published in Circulation (New York, N.Y.) (04-09-2001)
    “…The purpose of this study was to determine the efficacy of stent-based delivery of sirolimus (SRL) alone or in combination with dexamethasone (DEX) to reduce…”
    Get full text
    Journal Article
  4. 4

    Drug-eluting stents: Sirolimus and paclitaxel differentially affect cultured cells and injured arteries by Parry, Tom J., Brosius, Ruth, Thyagarajan, Rathna, Carter, Demetrius, Argentieri, Dennis, Falotico, Robert, Siekierka, John

    Published in European journal of pharmacology (07-11-2005)
    “…Sirolimus and paclitaxel eluted from stents inhibit cell proliferation and other cellular processes by dramatically different mechanisms. In this study, the…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Microstructure and drug-release studies of sirolimus-containing poly(lactide-co-glycolide) films by Ro, Andrew J., Falotico, Robert, Davé, Vipul

    “…Sirolimus‐containing poly(lactide‐co‐glycolide) (PLGA) films were prepared by solution casting and removing the residual solvent, 1,4‐dioxane, by liquid and…”
    Get full text
    Journal Article
  7. 7

    Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent by Klugherz, Bruce D, Llanos, Gerard, Lieuallen, Warren, Kopia, Gregory A, Papandreou, George, Narayan, Pallassana, Sasseen, Brett, Adelman, Steven J, Falotico, Robert, Wilensky, Robert L

    Published in Coronary artery disease (01-05-2002)
    “…BACKGROUNDIn-stent restenosis is caused by neointimal hyperplasia. Sirolimus (rapamycin; Wyeth Research, Radnor, Pennsylvania, USA) inhibits vascular smooth…”
    Get full text
    Journal Article
  8. 8

    The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit by Herbert, J M, Dol, F, Bernat, A, Falotico, R, Lalé, A, Savi, P

    Published in Thrombosis and haemostasis (01-09-1998)
    “…It is unknown whether the addition of aspirin might increase both the efficacy and the potency of clopidogrel, a potent and selective ADP blocker. For that…”
    Get more information
    Journal Article
  9. 9

    Update on sirolimus drug-eluting stents by Kipshidze, Nicholas, Leon, Martin B, Tsapenko, Mykola, Falotico, Robert, Kopia, Gregory A, Moses, Jeffrey

    Published in Current pharmaceutical design (01-01-2004)
    “…Percutaneous transluminal coronary angioplasty (PTCA) has become the main method of coronary revascularization. However, despite technical advancement,…”
    Get more information
    Journal Article
  10. 10

    A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization by Morice, Marie-Claude, Serruys, Patrick W, Sousa, J. Eduardo, Fajadet, Jean, Ban Hayashi, Ernesto, Perin, Marco, Colombo, Antonio, Schuler, G, Barragan, Paul, Guagliumi, Giulio, Molnàr, Ferenc, Falotico, Robert

    Published in The New England journal of medicine (06-06-2002)
    “…Despite advances in coronary angioplasty and stenting, restenosis remains an important problem that limits clinical success. This study compared a new coronary…”
    Get full text
    Journal Article
  11. 11

    Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model by CARTER, Andrew J, AGGARWAL, Meenakshi, KOPIA, Gregory A, TIO, Fermin, TSAO, Philip S, KOLATA, Ron, YEUNG, Alan C, LLANOS, Gerald, DOOLEY, John, FALOTICO, Robert

    Published in Cardiovascular research (01-09-2004)
    “…Stent-based delivery of sirolimus (SRL) has shown reduction in neointimal hyperplasia and restenosis. The purpose of this study was to evaluate the chronic…”
    Get full text
    Journal Article
  12. 12

    Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up by Sousa, J E, Costa, M A, Abizaid, A C, Rensing, B J, Abizaid, A S, Tanajura, L F, Kozuma, K, Van Langenhove, G, Sousa, A G, Falotico, R, Jaeger, J, Popma, J J, Serruys, P W

    Published in Circulation (New York, N.Y.) (23-10-2001)
    “…We have previously reported a virtual absence of neointimal hyperplasia 4 months after implantation of sirolimus-eluting stents. The aim of the present…”
    Get full text
    Journal Article
  13. 13

    Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents by SOUSA, J. Eduardo, COSTA, Marco A, SERRUYS, Patrick W, SOUSA, Amanda G. M. R, ABIZAID, Alexandre, FERES, Fausto, SEIXAS, Ana C, TANAJURA, Luiz F, MATTOS, Luiz A, FALOTICO, Robert, JAEGER, Judith, POPMA, Jeffrey J

    Published in Circulation (New York, N.Y.) (10-05-2005)
    “…Despite the proven superiority of sirolimus-eluting stents (SESs) compared with bare stents in the first year after implantation, long-term outcomes of…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Morphological and degradation studies of sirolimus-containing poly(lactide-co-glycolide) discs by Ro, Andrew J., Falotico, Robert, Davé, Vipul

    “…The effect of residual solvent and copolymer ratio on the in vitro degradation and drug release behavior of a bioabsorbable polymer/drug system was…”
    Get full text
    Journal Article
  17. 17

    A nonelutable low-molecular weight heparin stent coating for improved thromboresistance by Zhao, Jonathon, Falotico, Robert, Nguyen, Thai, Cheng, Yan, Parker, Theodore, Davé, Vipul, Rogers, Campbell, Riesenfeld, Johan

    “…Low‐molecular weight heparin (LMWH) has been widely used as a systemic anticoagulant during percutaneous coronary intervention. In this study, LMWH was…”
    Get full text
    Journal Article
  18. 18

    Control of cilostazol release kinetics and direction from a stent using a reservoir-based design by Parker, Theodore, Davé, Vipul, Falotico, Robert, Zhao, Jonathon, Nguyen, Thai, He, Sylvia, Sun, Yi-Ping, Rogers, Campbell

    “…Sustained release formulations of a potent antithrombotic drug, cilostazol, in poly‐(lactic acid‐co‐glycolic acid) (PLGA) matrices were created for luminal…”
    Get full text
    Journal Article
  19. 19
  20. 20